Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100737
Status:
TERMINATED
Last Update Posted:
2006-02-06
First Post:
2005-01-06
Brief Title:
Comparing Interleukin-2 IL-2 Combined With Rituximab Rituxan to Rituximab Alone in Subjects With Non-Hodgkins Lymphoma NHL
Sponsor:
Organization:
Chiron Corporation